Current Immunotherapies for Sarcoma: Clinical Trials and Rationale

Figure 1

The stepwise signaling necessary for T-cell activation against tumor targets represents areas of active investigation for the immunotherapy of sarcoma (TCR: T-cell receptor; WES: whole exome sequencing).